Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 12,962,959Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 22care4 ApS

02 2AbZ-Pharma GmbH

03 12Accord healthcare

04 25Amgen Inc

05 2Apotex Fermentation Inc.

06 2Apotex Inc

07 4Hangzhou Jiuyuan Gene Engineering

08 2Hexal AG

09 13Hospira, Inc.

10 2Instituto Biologico Contemporaneo

11 4Kashiv BioSciences

12 1Landsteiner

13 3Northern Medical Group ApS

14 4ORIFARM GROUP AS

15 6Pfizer Consumer Healthcare

16 4Pfizer Inc

17 2Pooyesh Darou Biopharmaceutical Co.

18 4Ratiopharm GmbH

19 17Sandoz B2B

20 1Siam Bioscience

21 2TANVEX BIOPHARMA USA, INC.

22 2Tanvex BioPharma

23 12Teva Pharmaceutical Industries

24 1UAB "Sicor Biotech"

25 1UAB SICOR BIOTECH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

filgrastim

Brand Name : Accofil

Dosage Form : INJECTION / INFUSION

Dosage Strength : 48 MU / 0.5 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

filgrastim

Brand Name : Accofil

Dosage Form : INJECTION / INFUSION

Dosage Strength : 30 MU / 0.5 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM

Brand Name : NEUPOGEN

Dosage Form : VIAL

Dosage Strength : 300MCG/1ML

Packaging :

Approval Date :

Application Number : 103353

Regulatory Info :

Registration Country : USA

blank

04

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM

Brand Name : NEUPOGEN

Dosage Form : VIAL

Dosage Strength : 480MCG/1.6ML

Packaging :

Approval Date :

Application Number : 103353

Regulatory Info :

Registration Country : USA

blank

05

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM

Brand Name : NEUPOGEN

Dosage Form : SYRINGE

Dosage Strength : 300MGC/0.5ML

Packaging :

Approval Date :

Application Number : 103353

Regulatory Info :

Registration Country : USA

blank

06

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM

Brand Name : NEUPOGEN

Dosage Form : SYRINGE

Dosage Strength : 480MCG/0.8ML

Packaging :

Approval Date :

Application Number : 103353

Regulatory Info :

Registration Country : USA

blank

07

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AAFI

Brand Name : NIVESTYM

Dosage Form : VIAL;SINGLE-DOSE

Dosage Strength : 300MCG/ML

Packaging :

Approval Date :

Application Number : 761080

Regulatory Info :

Registration Country : USA

blank

08

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AAFI

Brand Name : NIVESTYM

Dosage Form : VIAL;SINGLE-DOSE

Dosage Strength : 480MCG/1.6ML

Packaging :

Approval Date :

Application Number : 761080

Regulatory Info :

Registration Country : USA

blank

09

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AAFI

Brand Name : NIVESTYM

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 300MCG/0.5ML

Packaging :

Approval Date :

Application Number : 761080

Regulatory Info :

Registration Country : USA

blank

10

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AAFI

Brand Name : NIVESTYM

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 480MCG/0.8ML

Packaging :

Approval Date :

Application Number : 761080

Regulatory Info :

Registration Country : USA

blank

11

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AYOW

Brand Name : RELEUKO

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 300MCG/ML/VIAL

Packaging :

Approval Date :

Application Number : 761082

Regulatory Info :

Registration Country : USA

blank

12

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AYOW

Brand Name : RELEUKO

Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS

Dosage Strength : 480MCG/1.6ML/VIAL

Packaging :

Approval Date :

Application Number : 761082

Regulatory Info :

Registration Country : USA

blank

13

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AYOW

Brand Name : RELEUKO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300MCG/0.5ML

Packaging :

Approval Date :

Application Number : 761082

Regulatory Info :

Registration Country : USA

blank

14

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-AYOW

Brand Name : RELEUKO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 480MCG/0.8ML

Packaging :

Approval Date :

Application Number : 761082

Regulatory Info :

Registration Country : USA

blank

15

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-SNDZ

Brand Name : ZARXIO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 300 mcg/0.5 mL

Packaging :

Approval Date :

Application Number : 125553

Regulatory Info :

Registration Country : USA

blank

16

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-SNDZ

Brand Name : ZARXIO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 480 mcg/0.8 mL

Packaging :

Approval Date :

Application Number : 125553

Regulatory Info :

Registration Country : USA

blank

17

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-TXID

Brand Name : NYPOZI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 300MCG/0.5ML

Packaging :

Approval Date :

Application Number : 761126

Regulatory Info :

Registration Country : USA

blank

18

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

FILGRASTIM-TXID

Brand Name : NYPOZI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 480MCG/0.8ML

Packaging :

Approval Date :

Application Number : 761126

Regulatory Info :

Registration Country : USA

blank

19

AbZ-Pharma GmbH

Country
STLE Annual Meeting
Not Confirmed
arrow

AbZ-Pharma GmbH

Country
arrow
STLE Annual Meeting
Not Confirmed

filgrastim

Brand Name : Biograstim

Dosage Form : INJECTION / CONCENTRATE FOR

Dosage Strength : 48 MIU

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

20

AbZ-Pharma GmbH

Country
STLE Annual Meeting
Not Confirmed
arrow

AbZ-Pharma GmbH

Country
arrow
STLE Annual Meeting
Not Confirmed

filgrastim

Brand Name : Biograstim

Dosage Form : INJECTION / CONCENTRATE FOR

Dosage Strength : 30 MIU

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank